Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2025)

PROCEPT BioRobotics has reported EBT Margin over the past 6 years, most recently at 38.82% for Q4 2025.

  • Quarterly results put EBT Margin at 38.82% for Q4 2025, down 1173.0% from a year ago — trailing twelve months through Dec 2025 was 30.96% (up 959.0% YoY), and the annual figure for FY2025 was 30.96%, up 959.0%.
  • EBT Margin for Q4 2025 was 38.82% at PROCEPT BioRobotics, down from 25.7% in the prior quarter.
  • Over the last five years, EBT Margin for PRCT hit a ceiling of 24.73% in Q2 2025 and a floor of 180.98% in Q4 2021.
  • Median EBT Margin over the past 5 years was 73.26% (2023), compared with a mean of 88.32%.
  • Biggest five-year swings in EBT Margin: surged 40721bps in 2021 and later crashed -1173bps in 2025.
  • PROCEPT BioRobotics' EBT Margin stood at 180.98% in 2021, then skyrocketed by 42bps to 104.78% in 2022, then soared by 40bps to 62.93% in 2023, then skyrocketed by 57bps to 27.09% in 2024, then tumbled by -43bps to 38.82% in 2025.
  • The last three reported values for EBT Margin were 38.82% (Q4 2025), 25.7% (Q3 2025), and 24.73% (Q2 2025) per Business Quant data.